Elevated calcitonin and procalcitonin levels in nonmedullary benign and malignant thyroid nodules.

Abstract

Background. To evaluate the elevation rate of serum markers calcitonin (CT) and procalcitonin (ProCT) in patients with non-medullary benign and malignant thyroid nodules. Methods. Before surgery CT and ProCT were measured in sera from 168 patients with histologically proven benign thyroid nodules (n=107) and non-medullary thyroid carcinomas (n=61). Sera… (More)
DOI: 10.1111/j.1365-2265.2009.03733.x

3 Figures and Tables

Topics

  • Presentations referencing similar topics